Medicamen Biotech Ltd

Intimation Of Book Clsoure And Record Date In Accordance With Regulation 42 Of The SEBI (Listing Obligationa And Disclosure Requirements) Regulation 2015

The Company has fixed Saturday, September 19, 2026 as the record date for determining the entitlement of members to receive the dividend, if declared at the ensuing AGM.

Corp. Action / Record Date View filing →

Newspaper Publication

Announcement under Regulation 30 (LODR)- Newspaper Publication for the Unaudited Standalone and Consolidated Financial Results for the Qtr ended 30.06.2026

Company Update / Newspaper Publication View filing →

Corpoarte Action - Fixes Record Date As September 19, 2026 For The Purpose Of Declaration Of Final Dividend For The FY 2025-26.

Corporate Action- Fixes Record Date as September 19, 2026 for the purpose of declaration of final dividend for FY 2025-26.

Corp. Action / Record Date View filing →

Closure Of Register Of Members And Share Transfer Books

Board of Directors has been approved the closure of Register of Members and Share Transfer Books from September 19, 2026 to September 25, 2026 in connection with the proposed payment of ....

Corp. Action / Book Closure View filing →

Board Meeting Intimation for Considering And Approving The Unaudited Financial Results For The Quarter Ended 30 June 2026.

Medicamen Biotech Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve the Unaudited Financial ....

Board Meeting / Board Meeting View filing →

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Compliance Certificate under Reg 74(5) of SEBI (DP) Regulations, 2018

Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

Closure of Trading Window

Intimation for closure of trading window

Insider Trading / SAST / Closure of Trading Window View filing →